Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 2
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices
Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness, and Clinical Horizons (Part 2)
William Leonard Pickard interviews Bryan Hubbard about the new policy frontier of Ibogaine
Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice; Makary’s Priority Voucher Pilot Launches, Mentions Innovative PTSD Treatments; HALT Fentanyl Act Could...
June 2025 Psychedelic Patent Update
Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics
Mattha Busby: Power, Pleasure, and the Psychedelic Movement’s Reckoning
Dylan Beynon – Mindbloom – At Home Ketamine
Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study
Beckley Execs Talk Phase 2b Data, Competition, and Phase 3 Plans
Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at...
Beyond the Endpoint: Industry Voices Reflect on Compass’ Phase 3 Readout
It’s Time to Push Back: Meta’s War on Psychedelic Voices
Victoria Litman – The Future of Psychedelic Regulation Is Local
Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr....
1
2
3
...
293
Page 2 of 293
